| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nastaran Talaee, Shataw Azadvar, Sanaz Khodadadi, Nahal Abbasi, Zahra Najafi Asli-Pashaki, Yasaman Mirabzadeh, Gita Kholghi, Shahin Akhondzadeh, Salar Vasegh. Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review. European journal of clinical pharmacology. 2024-04-01. PMID:38558317. |
comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of bdnf and depression in preclinical and clinical studies: a systematic review. |
2024-04-01 |
2024-04-04 |
human |
| Nastaran Talaee, Shataw Azadvar, Sanaz Khodadadi, Nahal Abbasi, Zahra Najafi Asli-Pashaki, Yasaman Mirabzadeh, Gita Kholghi, Shahin Akhondzadeh, Salar Vasegh. Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review. European journal of clinical pharmacology. 2024-04-01. PMID:38558317. |
brain-derived neurotrophic factor (bdnf) dysfunction is one of the most important mechanisms underlying depression. |
2024-04-01 |
2024-04-04 |
human |
| Nastaran Talaee, Shataw Azadvar, Sanaz Khodadadi, Nahal Abbasi, Zahra Najafi Asli-Pashaki, Yasaman Mirabzadeh, Gita Kholghi, Shahin Akhondzadeh, Salar Vasegh. Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review. European journal of clinical pharmacology. 2024-04-01. PMID:38558317. |
it seems that selective serotonin reuptake inhibitors (ssris) improve depression via affecting bdnf level. |
2024-04-01 |
2024-04-04 |
human |
| Nastaran Talaee, Shataw Azadvar, Sanaz Khodadadi, Nahal Abbasi, Zahra Najafi Asli-Pashaki, Yasaman Mirabzadeh, Gita Kholghi, Shahin Akhondzadeh, Salar Vasegh. Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review. European journal of clinical pharmacology. 2024-04-01. PMID:38558317. |
in this systematic review, for the first time, we aimed to review the effect of three ssris including fluoxetine, escitalopram, and sertraline, on both depression and bdnf level in preclinical and clinical studies. |
2024-04-01 |
2024-04-04 |
human |
| Nastaran Talaee, Shataw Azadvar, Sanaz Khodadadi, Nahal Abbasi, Zahra Najafi Asli-Pashaki, Yasaman Mirabzadeh, Gita Kholghi, Shahin Akhondzadeh, Salar Vasegh. Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review. European journal of clinical pharmacology. 2024-04-01. PMID:38558317. |
in conclusion, it seems that ssris are reliable antidepressants, and the improvement effect of ssris on depression is not dependent to bdnf level (at least in human studies). |
2024-04-01 |
2024-04-04 |
human |
| Tathagata Biswas, Biswa Ranjan Mishra, Rituparna Maiti, Susanta Kumar Padhy, Archana Mishr. Efficacy and safety of low-dose amisulpride versus olanzapine-fluoxetine combination in post-schizophrenic depression: A randomized controlled trial. Journal of psychiatric research. vol 173. 2024-04-01. PMID:38560960. |
the calgary depression scale for schizophrenia (cdss), the clinical global impression-severity (cgi-s) and serum bdnf levels were assessed at baseline and after eight weeks of treatment. |
2024-04-01 |
2024-04-04 |
Not clear |
| Zhou Yang, Yalin Zhao, Yanling Wang, Xiaoli Liu, Yongxia Jiang, Yongqu Jiang, Tingyu Liu, Yue Hu, Hui Chan. Echinacoside ameliorates post-stroke depression by activating BDNF signaling through modulation of Nrf2 acetylation. Phytomedicine : international journal of phytotherapy and phytopharmacology. vol 128. 2024-03-28. PMID:38547621. |
echinacoside ameliorates post-stroke depression by activating bdnf signaling through modulation of nrf2 acetylation. |
2024-03-28 |
2024-03-31 |
Not clear |
| Weronika Zwolińska, Karolina Bilska, Kateryna Tarhonska, Edyta Reszka, Maria Skibińska, Natalia Pytlińska, Agnieszka Słopień, Monika Dmitrzak-Węglar. Biomarkers of Depression among Adolescent Girls: BDNF and Epigenetics. International journal of molecular sciences. vol 25. issue 6. 2024-03-28. PMID:38542252. |
biomarkers of depression among adolescent girls: bdnf and epigenetics. |
2024-03-28 |
2024-03-30 |
human |
| Weronika Zwolińska, Karolina Bilska, Kateryna Tarhonska, Edyta Reszka, Maria Skibińska, Natalia Pytlińska, Agnieszka Słopień, Monika Dmitrzak-Węglar. Biomarkers of Depression among Adolescent Girls: BDNF and Epigenetics. International journal of molecular sciences. vol 25. issue 6. 2024-03-28. PMID:38542252. |
alterations in brain-derived neurotrophic factor (bdnf) expression have been suggested to mediate the influence of environmental factors on the emergence of depression through epigenetic modifications. |
2024-03-28 |
2024-03-30 |
human |
| Valerio Dell'Oste, Lionella Palego, Laura Betti, Sara Fantasia, Davide Gravina, Andrea Bordacchini, Virginia Pedrinelli, Gino Giannaccini, Claudia Carmass. Plasma and Platelet Brain-Derived Neurotrophic Factor (BDNF) Levels in Bipolar Disorder Patients with Post-Traumatic Stress Disorder (PTSD) or in a Major Depressive Episode Compared to Healthy Controls. International journal of molecular sciences. vol 25. issue 6. 2024-03-28. PMID:38542503. |
to search for ptsd or depression biomarkers that would help clinicians define bd presentations, this study aimed at preliminarily evaluating circulating brain-derived-neurotrophic factor (bdnf) levels in bd subjects with ptsd or experiencing a major depressive episode versus controls. |
2024-03-28 |
2024-03-30 |
human |
| Yuhua Jin, Lamei Yu, Yan L. Paroxetine Effect on Nerve Growth Factor, Human Neurotrophin-4, Brain-Derived Neurotrophic Factor Levels in Post-stroke Depression. Molecular neurobiology. 2024-03-05. PMID:38443730. |
the aim of this study is to explore paroxetine's effect on nerve growth factor (ngf), human neurotrophin-4 (nt-4), and brain-derived neurotrophic factor (bdnf) levels in post-stroke depression. |
2024-03-05 |
2024-03-08 |
human |
| Yuhua Jin, Lamei Yu, Yan L. Paroxetine Effect on Nerve Growth Factor, Human Neurotrophin-4, Brain-Derived Neurotrophic Factor Levels in Post-stroke Depression. Molecular neurobiology. 2024-03-05. PMID:38443730. |
the levels of ngf, nt-4, bdnf, 5-hydroxytryptamine (5-ht), homocysteine (hcy), noradrenaline (ne), hamilton depression scale (hamd) changes of national institute of health stroke scale (nihss). |
2024-03-05 |
2024-03-08 |
human |
| En Zhao, Qian Yu, Meilei Wang, Zhengqiu Wang, Bin Jiang, Xiang Ma, Bin Zhou, Qingyong Dai, Jinyu Li, Shiming Wang, Fengjuan Chen, Xiaojun Yan. Value of serum brain-derived neurotrophic factor and glial fibrillary acidic protein for detecting depression in patients with Helicobacter pylori infection. Neuroscience letters. 2024-02-25. PMID:38403261. |
this study aimed to evaluate the value of serum brain-derived neurotrophic factor (bdnf) and glial fibrillary acidic protein (gfap) for predicting depression in h. pylori-positive patients. |
2024-02-25 |
2024-02-28 |
Not clear |
| Rong Wu, Ying Xiong, Yun Gu, Li-Yue Cao, Shu-Ying Zhang, Zhi-Xiu Song, Pu Fan, Lin Li. Traditional pediatric massage enhanced hippocampal GR, BDNF and IGF-1 expressions and exerted an anti-depressant effect in an adolescent rat model of CUMS-induced depression. Neuroscience. 2024-02-16. PMID:38364964. |
traditional pediatric massage enhanced hippocampal gr, bdnf and igf-1 expressions and exerted an anti-depressant effect in an adolescent rat model of cums-induced depression. |
2024-02-16 |
2024-02-19 |
rat |
| Ghida Hassan, Sherif A Kamar, Hagar Yousry Rady, Dina Sayed Abdelrahim, Nesma Hussein Abdel Hay Ibrahim, Noha N Lashee. A study of roflumilast treatment on functional and structural changes in hippocampus in depressed Adult male Wistar rats. PloS one. vol 19. issue 2. 2024-02-06. PMID:38315652. |
the current study aims to evaluate the role of protein kinase (pka)- camp response element-binding protein (creb)- brain derived neurotropic factor (bdnf) signaling pathway in depression and the effects of roflumilast (pde4 inhibitor) as potential antidepressant on the activity of the pka-creb-bdnf signaling pathway, histology, and pro-inflammatory cytokine production. |
2024-02-06 |
2024-02-09 |
rat |
| Suk Ling Ma, Katsie Tung Tang, Niki Cheuk Ting Lau, Clement Lek Hin Chiu, Cuichan Lin, Linda Chiu Wa Lam, Allen Ting Chun Le. Effect of computerized cognitive training on mood, cognition, and serum brain-derived neurotrophic factor level in late-life depression - a pilot randomized controlled trial. Frontiers in psychiatry. vol 14. 2024-02-01. PMID:38298930. |
the aim of this pilot randomized controlled trial was to test the feasibility of a computerized cognitive training targeting executive dysfunction in late-life depression and to investigate its impact on mood, cognition, and brain-derived neurotrophic factor (bdnf) levels. |
2024-02-01 |
2024-02-03 |
Not clear |
| Martyna Stanisławska, Maja Roman, Michał Nowick. The Plasma Neurofilament Light Chain, Brain-Derived Neurotrophic Factor, and Risk of Depression in Chronic Hemodialysis Patients. Biomedicines. vol 12. issue 1. 2024-01-23. PMID:38255209. |
understanding the relationship between the plasma neurofilament light chain (nfl) and brain-derived neurotrophic factor (bdnf) may help us to better understand the mechanisms of depression. |
2024-01-23 |
2024-01-25 |
Not clear |
| Ana Ribeiro-Davis, Dalia Y Al Saeedy, Fay M Jahr, Elisa Hawkins, Joseph L McClay, Laxmikant S Deshpand. Ketamine Produces Antidepressant Effects by Inhibiting Histone Deacetylases and Upregulating Hippocampal Brain-Derived Neurotrophic Factor Levels in a Diisopropyl Fluorophosphate-Based Rat Model of Gulf War Illness. The Journal of pharmacology and experimental therapeutics. vol 388. issue 2. 2024-01-17. PMID:37863487. |
interestingly, bdnf upregulation underlies ket's antidepressant effect in gwi-related depression. |
2024-01-17 |
2024-01-20 |
rat |
| Jian Xia, Meiling Chen, Heng Shao, Hui Chen, Shasha Zhu, Minjun Zhao, Wenting Luo, Jingjing Yang, Shaoyuan W. Inflammation and Late-Life Depression: Unraveling the Complex Relationship and Potential Therapeutic Strategies. Frontiers in bioscience (Landmark edition). vol 28. issue 12. 2024-01-05. PMID:38179753. |
changes in ca2+ homeostasis, cytokine levels, brain-derived neurotrophic factor (bdnf), white cell ratios, and the involvement of the nod-, lrr-, and pyrin domain-containing protein 3 (nlrp3) inflammasome have all been suggested as potential biomarkers that tie inflammation to late-life depression. |
2024-01-05 |
2024-01-07 |
Not clear |
| Omar Gammoh, Rand T Akasheh, Esam Qnais, Sara Al-Taber, Rabaa Y Athamneh, Amin A Hafiz, Abdelrahim Alqudah, Alaa A A Aljabali, Murtaza M Tambuwal. Unraveling the potential of vitamins C and D as adjuvants in depression treatment with escitalopram in an LPS animal model. Inflammopharmacology. 2024-01-05. PMID:38180676. |
depression is linked with oxidative stress and inflammation, where key players include nitric oxide (no), nuclear factor erythroid 2-related factor 2 (nrf2), brain-derived neurotrophic factor (bdnf), and heme oxidase-1 (ho-1). |
2024-01-05 |
2024-01-07 |
mouse |